| [1]Kirkham BW, Lassere MN, Edmonds JP, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort) [J]. Arthritis Rheum, 2006, 54 (4): 1122-1131. [2]Rohn TA, J ennings GT, Hernandez M, et al. Vaccination against IL-17 suppresses autoimmune art hritis and encephalomyelitis [J]. Eur J Immunol, 2006, 36 (11):2857-2867. [3]Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity [J]. Clin Immunol, 2008, 127 (3): 385-393 [4] Murata M, Fujimoto M, Matsushita T, et al. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? [J]. J Dermatol Sci, 2008, 50 (3): 240-242. [5] Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T Cells [J]. J Invest Dermatol, 2008, 128 (5): 1207-1211. [6] Koga C, Kabashima K, Shiraishi N, et al. Possible Pathogenic role of Th17 eells for atopic dermatitis [J].J Invest Dermatol, 2008, 128(11):2625-2630 [7] He D, Wu L, Kim H K, et al. CD8+IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses [J]. J Immunol, 2006, 177 (10): 6852-6858. [8] Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokineand chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation [J]. J Immunol, 2008; 180 (8): 5625 - 5635. [9] Aggarwal S ,Ghilardi N ,Xie MH et al .Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J]. J Bio Chem, 2003; 278(3): 1910-1914. [10] Wolk K,Witte E ,Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentation, and mobility in keratinocytes: a potential role in psoriasis [J]. Eur J Immunol, 2006; 36(5): 1309-1323. [11] Shen F, Gaffen SL. Structure-function relationships in the IL17 receptor: implications for signal transduction and therapy [J]. Cytokine, 2008; 41(2): 92-104. [12] Orihara K, Nakae S, Pawankar R, et al. Role of regulatory and proinflammatory T-cell populations in allergic diseases [J]. World Allergy Organization Journal, 2008, 1 (1): 9-14. [13] Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL 17+Thelper cells [J]. Cell, 2006, 126(6): 1121-1133. [14] Basak PY, Adiloglu AK, Ceyhan AM，et al.The role of helper and regulatory T cells in the pathogenesis of vitiligo [J]. J Am Acad Detmatol, 2009; 60(2):256-260. |
